Eye imaging and vision tests in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study uses advanced eye imaging (OCTA) and visual field testing to look at how multiple sclerosis affects the retina and optic nerve. The goal is to better understand the disease and potentially help track it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of multiple sclerosis (MS).
- You must be able to undergo eye imaging and visual field testing.
- Your vision must be sufficient to do the visual field test reliably.
- You must not have other eye diseases that affect the retina or optic nerve (like glaucoma or diabetic retinopathy).
- You must not have had a recent optic neuritis episode within the last 3–6 months.
- You must not have conditions like uncontrolled high blood pressure or diabetes that could affect the retina's blood vessels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced eye scans (OCT and retinal vessel imaging) to look for patterns in the retina that might be different in people with Multiple Sclerosis and other neuroinflammatory diseases. The goal is to find markers that could help doctors better understand and monitor these conditions.
This study tests how fast and how accurately your eyes process visual information and how eye movements look in people with multiple sclerosis. It may help researchers understand vision-related effects of MS using objective eye measurements.
This trial uses a type of eye scan (OCT) to look at the retina in people with brain conditions like multiple sclerosis, Alzheimer's, Parkinson's, or migraines. It aims to see if these scans can help doctors learn more about the disease and monitor it over time.
This study uses an eye-tracking camera and simple cognitive tests to look for early signs of thinking or memory problems in people with multiple sclerosis (MS). It may help find these issues sooner so they can be managed better.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This study checks how well new eye-tracking software can measure eye movements in people with multiple sclerosis. It may help researchers track changes in how the nervous system works using a simple camera-based eye test.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.